Team:Hong Kong CUHK/ianda
From 2013.igem.org
(Difference between revisions)
Janeytling (Talk | contribs) |
|||
(6 intermediate revisions not shown) | |||
Line 38: | Line 38: | ||
<style type="text/css"> | <style type="text/css"> | ||
<!-- | <!-- | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
body{background-color:#660099} | body{background-color:#660099} | ||
#globalWrapper { | #globalWrapper { | ||
Line 185: | Line 180: | ||
</div> | </div> | ||
+ | |||
+ | <div id="member" style="margin: 0px auto;"> | ||
+ | <div id="photo"><img src="https://static.igem.org/mediawiki/2013/6/6f/Skk2.jpg" width="271" height="360" hspace="50"></div> | ||
+ | <div id="description"> | ||
+ | <h1>Prof. Kong Siu-Kai</h1> | ||
+ | <p2> | ||
+ | <p>Prof. KONG's laboratory studies the process of apoptosis. In particular, he is interested in elucidating how mitochondria regulate the apoptosis in 'normal' and drug-resistant cancer cells. He wonders how the resistance of mitochondria to MMP can explain the resistance of cancer cells to apoptosis induction, and he hopes to develop strategies for overcoming chemotherapy resistance by targeting tumor mitochondria. He believes that pharmacological interventions on mitochondria are good strategies to promote cell death in tumor cells. This research topic on apoptosis is therefore relevant to disease treatment with socioeconomic impacts.</p> | ||
+ | </p2> | ||
+ | </div> | ||
+ | </div> | ||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
+ | |||
<div id="member" style="margin: 0px auto;"> | <div id="member" style="margin: 0px auto;"> | ||
<div id="photo"><img src="https://static.igem.org/mediawiki/2013/b/b2/Stephen.JPG" height="100%" hspace="50"></div> | <div id="photo"><img src="https://static.igem.org/mediawiki/2013/b/b2/Stephen.JPG" height="100%" hspace="50"></div> | ||
Line 206: | Line 222: | ||
</p2> | </p2> | ||
<p> | <p> | ||
- | <p2>Hi, I am a | + | <p2>Hi, I am a graduate student studying Bioinformatics at CUHK. My research interests focus on cancer genetics and genomics, next generation sequencing analysis, and computational biology. I am very glad to join this team. I appreciate the opportunity to participate in the iGEM competition, which is an icon of innovation. In my spare time, I enjoy reading, travelling, playing badminton, dancing and hiking. |
</p2> | </p2> | ||
</p> | </p> | ||
Line 217: | Line 233: | ||
<p2> | <p2> | ||
<p>Full name: Jacky, Fong Chuen, Loo</p> | <p>Full name: Jacky, Fong Chuen, Loo</p> | ||
- | <p>Programme of study: Life Science | + | <p>Programme of study: Life Science PG3</p> |
<p>Jacky is a third-year PhD student in School of Life Science at CUHK. His research focus is aptamer technology and its integration on bio-sensors development for downstream applications. He also studies the mechanism of multi-drug resistant cancer, focusing on the organelle-specific targeted drug action.</p> | <p>Jacky is a third-year PhD student in School of Life Science at CUHK. His research focus is aptamer technology and its integration on bio-sensors development for downstream applications. He also studies the mechanism of multi-drug resistant cancer, focusing on the organelle-specific targeted drug action.</p> | ||
</p2> | </p2> |
Latest revision as of 12:45, 8 May 2014